Facebook Instagram Linkedin Soundcloud Twitter Youtube
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Search
FDAReview.org A PROJECT OF THE INDEPENDENT INSTITUTE
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate

What Exactly Does Trump’s Executive Order Do for Marijuana Reclassification?

Raymond March - January 9, 2026
Any marijuana-related policy garners considerable attention from medical professionals, lawyers, politicians, and, of course, the general public. President Trump’s recent executive order provides another...

A Real Test for New FDA Reforms

Raymond March - January 2, 2026
National public health policy under the leadership of Department of Health and Human Services Secretary Robert F. Kennedy Jr. made no shortage of headlines...

Legalize Marijuana to Ease the Opioid Crisis

Raymond March - November 11, 2025

More FDA Turnover, Same FDA Problems

Raymond March - August 11, 2025

Food Dye Bans Should Be Left to the States

Raymond March - June 9, 2025

Will the FDA Make 2025 the Year of Healthy Eating?

Raymond March - January 10, 2025

RFK, Vaccines, and the FDA

Raymond March - January 7, 2025

Ozempic Shortage Exposes FDA Challenges—but Telemedicine Offers Hope

Raymond March - December 30, 2024

Don’t Trust the Cabinet, Trust the Market

Raymond March - December 6, 2024

COVID-19 Vaccines and the Ratchet Effect: Lessons from Crisis and Leviathan

If the FDA Wants People to Stop Smoking, it Should Stop Meddling in the Vaping Market

Supply, Demand, and Wegovy

What Would Kamala Harris’s FDA Look Like?

The Controversy Surrounding Microdosing Chocolate Bars

Raymond March - July 25, 2024
California-based company Diamond Shruumz was once one of the premier providers of microdosing products in the US. Providing “artisanal chocolates… designed for creative souls,”...

The FDA Is Coming After Microdosing Chocolate Bars

Raymond March - June 17, 2024
Diamond Shruumz chocolate bars come in various popular flavors, including dark chocolate, cookies and cream, fruity cereal, and birthday cake. Each bar costs about...

Why Are So Many Food and Beverage Products Being Recalled?

Raymond March - June 13, 2024

The FDA Is Not a Referee

Raymond March - May 3, 2024

Will the Blundering FDA Receive More Power?

Raymond March - April 24, 2024

DEA and FDA Duke it Out Over Marijuana Scheduling

Raymond March - April 19, 2024

You Can’t Spend Your Way Out of an Opioid Crisis

Raymond March - April 15, 2024

Did Healthcare Spending Really Return to Pre-Pandemic Levels?

Raymond March - January 24, 2024

Another Infant Formula Shortage? Blame the FDA

Raymond March - January 22, 2024

Gene Therapy: A Promising Medical Frontier Hindered by Regulatory Roadblocks

Raymond March - December 8, 2023

Who Should Decide if Weight-Loss Injections Should be Prescribed for Kids?

Raymond March - December 4, 2023

More Oversight Won’t Help the US Baby Formula Market

Raymond March - November 20, 2023

The FDA Should Stay Away from Laboratory Developed Tests

Raymond March - November 16, 2023

The Pandemic is Over, But Pandemic Policies Are Not

Raymond March - September 19, 2023

FDA Efforts to Curb Youth Vaping Continue to Come Up Short

Raymond March - September 5, 2023

The FDA Loosens Blood Donation Restrictions, Finally

Raymond March - July 7, 2023

Recent Attacks on Recreational Marijuana Legalization Are All Smoke

Raymond March - June 22, 2023

Are Insulin Prices About to Drop? The Devil is in the Details

Raymond March - April 28, 2023

FDA’s Rare Positive Move

Raymond March - April 4, 2023

Insulin Price-Caps: A Solution or a Recipe for Rationing?

Raymond March - March 31, 2023
© Newspaper WordPress Theme by TagDiv